Home / CELU : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CELU make money? Does CELU have pricing power? What's the Earnings Whisper? Will CELU profit more as the business scales? What is CELU's management track record? Is CELU's current price justified?

Celularity Inc.

$1.4 +$0.19 (+15.70%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$1.41

Day Range

$1.32$1.43

Year Range

$0.56$2.55

Market Cap

40.52M

AVG Volume

134.75K

Trailing/Forward PE

-0.38/0.93

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

NASDAQ

Revenue (USD)

CELU Revenue (USD) by year
Period	Revenue (USD)
2025	26.55M
2024	54.22M
2023	22.77M
2022	17.97M
2021	21.34M
2020	14.28M
2019	5.15M

Net Income (USD)

CELU Net Income (USD) by year
Period	Net Income (USD)
2025	-91.71M
2024	-57.89M
2023	-196.29M
2022	14.19M
2021	-100.12M
2020	-208.23M
2019	-20.48M

Operating Income (USD)

CELU Operating Income (USD) by year
Period	Operating Income (USD)
2025	-61.31M
2024	-38.36M
2023	-192.29M
2022	-25.6M
2021	-109.06M
2020	-151.93M
2019	-32.68M

EBITDA (USD)

CELU EBITDA (USD) by year
Period	EBITDA (USD)
2025	-77.62M
2024	-41.7M
2023	-205.01M
2022	-32.55M
2021	-88.11M
2020	-76.09M
2019	-16.3M

Cash Flows (USD)

CELU Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-13.25M
2024	-6.56M
2023	-42.73M
2022	-143.11M
2021	-161.54M
2020	-91.03M
2019	-1.1M

EPS (USD)

CELU EPS (USD) by year
Period	EPS (USD)
2025	-3.69
2024	-2.65
2023	-11.33
2022	0.3
2021	-57.15
2020	-92.25
2019	-8.78

Expenses (USD)

CELU Expenses (USD) by year
Period	Expenses (USD)
2025	66.29M
2024	76.19M
2023	193.43M
2022	149.62M
2021	168.68M
2020	102.43M
2019	23.03M

Cash & Debt (USD)

CELU Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	6.17M
2024	738K
2023	227K
2022	13.97M
2021	37.24M
2020	54.31M
2019	28.13M

Debt ratios

CELU Debt ratios by year
Period	Debt ratios
2025	-0.1
2024	-0.19
2023	-0.16
2022	-0.24

Margins

CELU Margins by year
Period	Margins
2025	76.04%
2024	72.36%
2023	29.66%
2022	-9.4%
2021	54.76%
2020	65.46%
2019	66.39%

Return on Capital

CELU Return on Capital by year
Period	Return on Capital
2025	240.96%
2024	-655.11%
2023	-479.24%
2022	7.14%
2021	-100.7%
2020	-1112.77%
2019	-14.85%

Shares Outstanding

CELU Shares Outstanding by year
Period	Shares Outstanding
2025	25.6M
2024	22.35M
2023	19.38M
2022	14.89M
2021	12.41M
2020	1.84M
2019	2.39M

Book Value Per Share (USD)

CELU Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	-1.49
2024	0.4
2023	2.11
2022	13.36
2021	8.01
2020	10.15
2019	57.56

Total Assets (USD)

CELU Total Assets (USD) by year
Period	Total Assets (USD)
2025	107.33M
2024	132.68M
2023	143.89M
2022	401.07M
2021	414.13M
2020	431.01M
2019	521.5M

Employee Count

CELU Employee Count by year
Period	Employee Count
2025	115
2024	123
2023	120
2022	225
2021	225
2019	4

PE Ratio

CELU PE Ratio by year
Period	PE Ratio
Aug 23	3.81
Aug 23	4.31
Jul 23	4.68
Jul 23	6.71
Jul 23	5.93
Jul 23	5.96
Jun 23	6.35
Jun 23	7.98
Jun 23	9.65
Jun 23	7.79
Jun 23	8.42
May 23	7.2
May 23	6.82
May 23	5.29
May 23	5.31
Apr 23	6.2
Apr 23	7.22
Apr 23	7.11
Apr 23	7.21
Mar 23	6.51
Nov 22	10.13
Oct 22	10.63
Oct 22	10.31
Oct 22	9.45
Oct 22	9.54
Sep 22	10.49
Sep 22	11.4
Sep 22	9.63
Sep 22	11.17
Sep 22	12.54
Aug 22	13.08
Aug 22	12.81
Aug 22	13.94

Free Cash Flow Yield

CELU Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-36.98%
Sep 26	-36.72%
Sep 26	-30.82%
Aug 26	-32.77%
Aug 26	-64.72%
Aug 26	-74.41%
Aug 26	-73.89%
Jul 26	-81.5%
Jul 26	-69.04%
Jul 26	-66.35%
Jul 26	-69.93%
Jul 26	-83.55%
Jun 26	-83.51%
Jun 26	-68.82%
Jun 26	-72.63%
Jun 26	-59.36%
May 26	-51.26%
May 26	-59.51%
May 26	-64.06%
May 26	-58.84%
May 26	-54.1%
Apr 26	-22.61%
Apr 26	-20.41%
Apr 26	-19.76%
Apr 26	-18.87%
Mar 26	-20.57%
Mar 26	-20.57%
Mar 26	-20.57%
Mar 26	-20.74%
Feb 26	-20.41%
Feb 26	-18.59%
Feb 26	-19.92%
Feb 26	-19.31%
Jan 26	-20.57%
Jan 26	-19.46%
Jan 26	-19.16%
Jan 26	-19.31%
Jan 26	-20.74%
Dec 25	-18.73%
Dec 25	-17.31%
Dec 25	-15.69%
Dec 25	-12.68%
Nov 25	-12.55%
Nov 25	-14.34%
Nov 25	-16.19%
Nov 25	-6.16%
Oct 25	-5.62%
Oct 25	-5.3%
Oct 25	-5.54%
Oct 25	-5.35%
Oct 25	-5.15%
Sep 25	-4.87%
Sep 25	-4.94%
Sep 25	-4.72%
Sep 25	-4.55%
Aug 25	-2.78%
Aug 25	-7.75%
Aug 25	-8.44%
Aug 25	-9.06%
Aug 25	-9.41%
Jul 25	-9.92%
Jul 25	-9.69%
Jul 25	-13.91%
Jul 25	-14.83%
Jun 25	-15.87%
Jun 25	-16.68%
Jun 25	-16.78%
Jun 25	-14.11%
May 25	-13.91%
May 25	-12.82%
May 25	-14.39%
May 25	-17.58%
May 25	-37.03%
Apr 25	-36.8%
Apr 25	-37.98%
Apr 25	-36.13%
Apr 25	-42.93%
Mar 25	-33.47%
Mar 25	-32.55%
Mar 25	-38.23%
Mar 25	-48.17%
Feb 25	-51.08%
Feb 25	-35.27%
Feb 25	-27.69%
Feb 25	-27.43%
Jan 25	-28.9%
Jan 25	-23.7%
Jan 25	-25.76%
Jan 25	-27.43%
Jan 25	-25.76%
Dec 24	-26.45%
Dec 24	-25.43%
Dec 24	-26.69%
Dec 24	-25.11%
Nov 24	-47.99%
Nov 24	-35.47%
Nov 24	-39.8%
Nov 24	-27.58%
Nov 24	-93.83%
Oct 24	-72.65%

Price to Sales

CELU Price to Sales by year
Period	Price to Sales
Sep 26	1.35
Sep 26	1.36
Sep 26	1.62
Aug 26	1.52
Aug 26	0.77
Aug 26	0.67
Aug 26	0.68
Jul 26	0.61
Jul 26	0.72
Jul 26	0.75
Jul 26	0.71
Jul 26	0.6
Jun 26	0.6
Jun 26	0.73
Jun 26	0.69
Jun 26	0.84
May 26	0.97
May 26	0.84
May 26	0.78
May 26	0.85
May 26	0.92
Apr 26	0.72
Apr 26	0.8
Apr 26	0.82
Apr 26	0.86
Mar 26	0.79
Mar 26	0.79
Mar 26	0.79
Mar 26	0.79
Feb 26	0.8
Feb 26	0.88
Feb 26	0.82
Feb 26	0.84
Jan 26	0.79
Jan 26	0.84
Jan 26	0.85
Jan 26	0.84
Jan 26	0.79
Dec 25	0.87
Dec 25	0.94
Dec 25	1.04
Dec 25	1.29
Nov 25	1.3
Nov 25	1.14
Nov 25	1.01
Nov 25	0.96
Oct 25	1.05
Oct 25	1.12
Oct 25	1.07
Oct 25	1.1
Oct 25	1.15
Sep 25	1.21
Sep 25	1.2
Sep 25	1.25
Sep 25	1.3
Aug 25	2.12
Aug 25	1.56
Aug 25	1.43
Aug 25	1.34
Aug 25	1.29
Jul 25	1.22
Jul 25	1.25
Jul 25	0.87
Jul 25	0.82
Jun 25	0.76
Jun 25	0.73
Jun 25	0.72
Jun 25	0.86
May 25	0.87
May 25	0.94
May 25	0.84
May 25	0.69
May 25	0.73
Apr 25	0.73
Apr 25	0.71
Apr 25	0.75
Apr 25	0.63
Mar 25	0.81
Mar 25	0.83
Mar 25	0.71
Mar 25	0.56
Feb 25	0.53
Feb 25	0.77
Feb 25	0.98
Feb 25	0.98
Jan 25	0.93
Jan 25	1.14
Jan 25	1.05
Jan 25	0.98
Jan 25	1.05
Dec 24	1.02
Dec 24	1.06
Dec 24	1.01
Dec 24	1.08
Nov 24	1.04
Nov 24	1.41
Nov 24	1.26
Nov 24	1.82
Nov 24	0.92
Oct 24	1.19

EV/EBITDA

CELU EV/EBITDA by year
Period	EV/EBITDA
Nov 22	7.19
Oct 22	7.56
Oct 22	7.32
Oct 22	6.69
Oct 22	6.76
Sep 22	7.46
Sep 22	8.12
Sep 22	6.82
Sep 22	7.96
Sep 22	8.96
Aug 22	9.36
Aug 22	9.16
Aug 22	9.99

Price to Book

CELU Price to Book by year
Period	Price to Book
Aug 25	9.59
Aug 25	8.8
Aug 25	8.2
Aug 25	7.89
Jul 25	7.49
Jul 25	7.66
Jul 25	5.34
Jul 25	5.01
Jun 25	4.68
Jun 25	4.45
Jun 25	4.43
Jun 25	5.26
May 25	5.34
May 25	5.79
May 25	5.16
May 25	4.22
May 25	2.03
Apr 25	2.05
Apr 25	1.98
Apr 25	2.09
Apr 25	1.76
Mar 25	2.25
Mar 25	2.31
Mar 25	1.97
Mar 25	1.56
Feb 25	1.48
Feb 25	2.14
Feb 25	2.72
Feb 25	2.75
Jan 25	2.61
Jan 25	3.18
Jan 25	2.93
Jan 25	2.75
Jan 25	2.93
Dec 24	2.85
Dec 24	2.96
Dec 24	2.82
Dec 24	3
Nov 24	1.6
Nov 24	2.17
Nov 24	1.93
Nov 24	2.79
Nov 24	0.99
Oct 24	1.28
Oct 24	1.72
Oct 24	1.19
Oct 24	1.25
Sep 24	1.41
Sep 24	1.41
Sep 24	1.32
Sep 24	1.33
Aug 24	1.46
Aug 24	1.49
Aug 24	1.45
Aug 24	1.33
Aug 24	1.43
Jul 24	1.95
Jul 24	1.88
Jul 24	1.84
Jul 24	1.83
Jun 24	1.95
Jun 24	1.9
Jun 24	2
Jun 24	2.02
May 24	1.94
May 24	2.15
May 24	1.87
May 24	1.84
May 24	2.05
Apr 24	1.88
Apr 24	1.89
Apr 24	2.56
Apr 24	3.31
Mar 24	3.26
Mar 24	3.23
Mar 24	3.54
Mar 24	3.85
Mar 24	2.28
Feb 24	2.89
Feb 24	2.7
Feb 24	2.66
Feb 24	3.36
Jan 24	2.14
Jan 24	1.83
Jan 24	1.35
Jan 24	1.53
Dec 23	0.37
Dec 23	0.27
Dec 23	0.28
Dec 23	0.31
Dec 23	0.34
Nov 23	0.32
Nov 23	0.31
Nov 23	0.33
Nov 23	0.35
Oct 23	0.31
Oct 23	0.35
Oct 23	0.44
Oct 23	0.32
Sep 23	0.33

No video analysis for this stock yet. Request one from our team.

News: CELU

gurufocus.com · 27 Aug 2026

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

[url="]Celularity Inc.[/url] (Nasdaq: CELU) (âCelularityâ), a longevity-focused regenerative and cellular medicine company, and [url="]MuseCell InnovationsÂ

businesswire.com · 27 Aug 2026

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

FLORHAM PARK, N.J. & SINGAPORE--(BUSINESS WIRE)--Celularity Inc. and MuseCell Innovations announce U.S. manufacturing partnership for production of Dezawa MuseCells in Florham Park, NJ facility.

globenewswire.com · 25 Aug 2026

Celularity Provides Update Regarding Nasdaq Listing Compliance

FLORHAM PARK, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”) today announced that, on August 21, 2026, it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC stating that, because the Company has not filed its Quarterly Report on Form 10-Q for the period ended June 30, 2026 and remains delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission.

AI Analysis

Celularity Inc.

Video analysis: CELU

News: CELU

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

Celularity Provides Update Regarding Nasdaq Listing Compliance

Similar companies